Cargando…

Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61

PURPOSE: One of the features in cancer development is the migration of cancer cells to form metastatic lesions. CYR61 protein promotes migration and the epithelial-mesenchymal transition in several cancer cell types. Evidence suggests that CYR61 and dexamethasone are relevant to colorectal cancer. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sanghoon, Bui, Ngoc Thuy, Ho, Manh Tin, Kim, Young Mee, Cho, Moonjae, Shin, Dong Bok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946372/
https://www.ncbi.nlm.nih.gov/pubmed/26693911
http://dx.doi.org/10.4143/crt.2015.209
_version_ 1782443016456241152
author Han, Sanghoon
Bui, Ngoc Thuy
Ho, Manh Tin
Kim, Young Mee
Cho, Moonjae
Shin, Dong Bok
author_facet Han, Sanghoon
Bui, Ngoc Thuy
Ho, Manh Tin
Kim, Young Mee
Cho, Moonjae
Shin, Dong Bok
author_sort Han, Sanghoon
collection PubMed
description PURPOSE: One of the features in cancer development is the migration of cancer cells to form metastatic lesions. CYR61 protein promotes migration and the epithelial-mesenchymal transition in several cancer cell types. Evidence suggests that CYR61 and dexamethasone are relevant to colorectal cancer. However, relationships between them and colorectal cancer are still unclear. Understanding the molecular mechanism of colorectal cancer progression related with CYR61 and dexamethasone, which is widely used for combination chemotherapy, is necessary for improved therapy. MATERIALS AND METHODS: We used colorectal cancer cells, HCT116, co-treated with transforming growth factor β1 (TGF-β1) and dexamethasone to examine the inhibitory migration effect of dexamethasone by migratory assay. Alternatively, both migratory pathways, expression of AKT and ERK, and the target factor CYR61 was also tested by co-treatment with TGF-β1 and dexamethasone. RESULTS: We report that dexamethasone significantly inhibited TGF-β1–induced cell migration, without affecting cell proliferation. Importantly, we observed that TGF-β1 promoted the epithelial-mesenchymal transition process and that dexamethasone co-treatment abolished this effect. ERK and AKT signaling pathways were found to mediate TGF-β1–induced migration, which was inhibited by dexamethasone. In addition, TGF-β1 treatment induced CYR61 expression whereas dexamethasone reduced it. These observations were compatible with the modulation of migration observed following treatment of HCT116 cells with human recombinant CYR61 and anti-CYR61 antibody. Our results also indicated that TGF-β1 enhanced collagen I and reduced matrix metalloproteinase 1 expression, which was reversed by dexamethasone treatment. CONCLUSION: These findings suggested that dexamethasone inhibits AKT and ERK phosphorylation, leading to decreased CYR61 expression, which in turn blocks TGF-β1–induced migration.
format Online
Article
Text
id pubmed-4946372
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-49463722016-07-18 Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61 Han, Sanghoon Bui, Ngoc Thuy Ho, Manh Tin Kim, Young Mee Cho, Moonjae Shin, Dong Bok Cancer Res Treat Original Article PURPOSE: One of the features in cancer development is the migration of cancer cells to form metastatic lesions. CYR61 protein promotes migration and the epithelial-mesenchymal transition in several cancer cell types. Evidence suggests that CYR61 and dexamethasone are relevant to colorectal cancer. However, relationships between them and colorectal cancer are still unclear. Understanding the molecular mechanism of colorectal cancer progression related with CYR61 and dexamethasone, which is widely used for combination chemotherapy, is necessary for improved therapy. MATERIALS AND METHODS: We used colorectal cancer cells, HCT116, co-treated with transforming growth factor β1 (TGF-β1) and dexamethasone to examine the inhibitory migration effect of dexamethasone by migratory assay. Alternatively, both migratory pathways, expression of AKT and ERK, and the target factor CYR61 was also tested by co-treatment with TGF-β1 and dexamethasone. RESULTS: We report that dexamethasone significantly inhibited TGF-β1–induced cell migration, without affecting cell proliferation. Importantly, we observed that TGF-β1 promoted the epithelial-mesenchymal transition process and that dexamethasone co-treatment abolished this effect. ERK and AKT signaling pathways were found to mediate TGF-β1–induced migration, which was inhibited by dexamethasone. In addition, TGF-β1 treatment induced CYR61 expression whereas dexamethasone reduced it. These observations were compatible with the modulation of migration observed following treatment of HCT116 cells with human recombinant CYR61 and anti-CYR61 antibody. Our results also indicated that TGF-β1 enhanced collagen I and reduced matrix metalloproteinase 1 expression, which was reversed by dexamethasone treatment. CONCLUSION: These findings suggested that dexamethasone inhibits AKT and ERK phosphorylation, leading to decreased CYR61 expression, which in turn blocks TGF-β1–induced migration. Korean Cancer Association 2016-07 2015-12-15 /pmc/articles/PMC4946372/ /pubmed/26693911 http://dx.doi.org/10.4143/crt.2015.209 Text en Copyright © 2016 by the Korean Cancer Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Han, Sanghoon
Bui, Ngoc Thuy
Ho, Manh Tin
Kim, Young Mee
Cho, Moonjae
Shin, Dong Bok
Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61
title Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61
title_full Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61
title_fullStr Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61
title_full_unstemmed Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61
title_short Dexamethasone Inhibits TGF-β1–Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61
title_sort dexamethasone inhibits tgf-β1–induced cell migration by regulating the erk and akt pathways in human colon cancer cells via cyr61
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946372/
https://www.ncbi.nlm.nih.gov/pubmed/26693911
http://dx.doi.org/10.4143/crt.2015.209
work_keys_str_mv AT hansanghoon dexamethasoneinhibitstgfb1inducedcellmigrationbyregulatingtheerkandaktpathwaysinhumancoloncancercellsviacyr61
AT buingocthuy dexamethasoneinhibitstgfb1inducedcellmigrationbyregulatingtheerkandaktpathwaysinhumancoloncancercellsviacyr61
AT homanhtin dexamethasoneinhibitstgfb1inducedcellmigrationbyregulatingtheerkandaktpathwaysinhumancoloncancercellsviacyr61
AT kimyoungmee dexamethasoneinhibitstgfb1inducedcellmigrationbyregulatingtheerkandaktpathwaysinhumancoloncancercellsviacyr61
AT chomoonjae dexamethasoneinhibitstgfb1inducedcellmigrationbyregulatingtheerkandaktpathwaysinhumancoloncancercellsviacyr61
AT shindongbok dexamethasoneinhibitstgfb1inducedcellmigrationbyregulatingtheerkandaktpathwaysinhumancoloncancercellsviacyr61